Crossmark

The Role of Targeted Agents and Immunotherapy in Older Patients with Non-small Cell Lung Cancer

Crossref DOI link: https://doi.org/10.1007/s40266-018-0573-z

Published Online: 2018-08-14

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gomes, Fabio

Tay, Rebecca

Chiramel, Jaseela

Califano, Raffaele http://orcid.org/0000-0003-2611-5319
License Information

Text and Data Mining valid from 2018-08-14
More Information

Article History

First Online: 14 August 2018

Compliance with Ethical Standards

:

: No funding was used in the preparation of this review article.

: RC has received honoraria for consultancy and advisory boards from BMS, MSD, Roche, AstraZeneca/Medimmune, Takeda and Novartis; RC declares not owning any stock in any of these companies. FG, RT and JC declare that they have no conflicts of interest that might be relevant to the contents of this review.